[Effect on various platelet parameters of dipyridamole (225 mg/day) acetylsalicylic acid (150 mg/day) and their combination in healthy volunteers]. 1985

A Aguilar Muñoz, and J P de la Cruz Cortés, and F Martos Crespo, and J de Pablo Molina, and F Sánchez de la Cuesta

UI MeSH Term Description Entries
D008297 Male Males
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic

Related Publications

A Aguilar Muñoz, and J P de la Cruz Cortés, and F Martos Crespo, and J de Pablo Molina, and F Sánchez de la Cuesta
January 2008, Clinical hemorheology and microcirculation,
A Aguilar Muñoz, and J P de la Cruz Cortés, and F Martos Crespo, and J de Pablo Molina, and F Sánchez de la Cuesta
October 1999, Clinical pharmacology and therapeutics,
A Aguilar Muñoz, and J P de la Cruz Cortés, and F Martos Crespo, and J de Pablo Molina, and F Sánchez de la Cuesta
November 1998, Zeitschrift fur Kardiologie,
A Aguilar Muñoz, and J P de la Cruz Cortés, and F Martos Crespo, and J de Pablo Molina, and F Sánchez de la Cuesta
January 2007, Acta odontologica latinoamericana : AOL,
A Aguilar Muñoz, and J P de la Cruz Cortés, and F Martos Crespo, and J de Pablo Molina, and F Sánchez de la Cuesta
January 1972, Scandinavian journal of haematology,
A Aguilar Muñoz, and J P de la Cruz Cortés, and F Martos Crespo, and J de Pablo Molina, and F Sánchez de la Cuesta
July 2016, Journal of clinical pharmacology,
A Aguilar Muñoz, and J P de la Cruz Cortés, and F Martos Crespo, and J de Pablo Molina, and F Sánchez de la Cuesta
September 2009, International journal of clinical pharmacology and therapeutics,
A Aguilar Muñoz, and J P de la Cruz Cortés, and F Martos Crespo, and J de Pablo Molina, and F Sánchez de la Cuesta
November 2006, Medizinische Monatsschrift fur Pharmazeuten,
A Aguilar Muñoz, and J P de la Cruz Cortés, and F Martos Crespo, and J de Pablo Molina, and F Sánchez de la Cuesta
November 1978, Pharmacological research communications,
A Aguilar Muñoz, and J P de la Cruz Cortés, and F Martos Crespo, and J de Pablo Molina, and F Sánchez de la Cuesta
January 2005, Thrombosis research,
Copied contents to your clipboard!